Clinical trials in Russia and Azerbaijan demonstrated safety o...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MOSCOW, Feb. 14, 2022 /PRNewswire-AsiaNet/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca's vaccine an...
Authors: LATEST ASIANET NEWS RELEASES